Carregant...
T40214/PEI Complex, a Potent Therapeutics for Prostate Cancer that Targets STAT3 Signaling
BACKGROUND: Prostate cancer is the most common cancer among men in American and the second leading cause of cancer death. The treatment options employed for patients with advanced and metastatic prostate cancer are limited. As a critical mediator of oncogenic signaling, STAT3 is active in 82% of pat...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2574665/ https://ncbi.nlm.nih.gov/pubmed/18615483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.20807 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|